VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ZVRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ZVRAZevra Therapeutics, Inc.
$14.34$848M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksZVRAQuarterly Financials

Zevra Therapeutics, Inc. (ZVRA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Zevra Therapeutics, Inc. (ZVRA) quarterly income statement — complete revenue, gross profit & net income history

ZVRA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue36.22M34.13M26.06M25.88M20.4M12.04M3.69M4.45M3.42M13.22M2.9M8.47M3.18M2.32M2.87M1.3M3.96M2.58M1.97M11.99M
Revenue Growth %77.54%183.36%605.36%481.73%495.65%-8.88%27.63%-47.47%7.84%469.94%0.73%551.54%-19.9%-10.19%46.26%-89.15%-67.28%9.13%2.08%73.51%
Cost of Goods Sold1.9M1.52M1.55M12.38M1.34M1.37M2.3M3.57M3.27M2.79M144K677K125K143K141K51K8K59K01M
COGS % of Revenue5.24%4.45%5.96%47.83%6.59%11.34%62.33%80.31%95.33%21.08%4.97%7.99%3.94%6.17%4.91%3.92%0.2%2.29%-8.34%
Gross Profit34.32M32.6M24.51M13.5M19.06M10.68M1.39M876K160K10.43M2.75M7.79M3.05M2.18M2.73M1.25M3.96M2.52M1.97M10.99M
Gross Margin %94.76%95.55%94.04%52.17%93.41%88.66%37.67%19.69%4.67%78.92%95.03%92.01%96.06%93.83%95.09%96.08%99.8%97.71%100%91.66%
Gross Profit Growth %80.12%205.38%1660.78%1441.32%11810%2.36%-49.4%-88.76%-94.76%379.37%0.66%523.94%-22.9%-13.75%39.08%-88.63%-64.41%6.64%2.08%75.33%
Operating Expenses25.18M23.29M20.37M84.54M24.42M26.09M28.7M24.67M20.65M25.1M18.11M14.04M15.88M11.43M9.36M26.02M5.82M5.37M4.19M5.15M
OpEx % of Revenue69.51%68.25%78.15%326.65%119.69%216.67%776.67%554.53%602.8%189.92%625.73%165.82%500.06%492.84%325.64%2001.23%146.68%207.78%213.08%42.99%
Selling, General & Admin20.78M20.35M16.93M20.78M19.55M16.13M16.21M12.6M9.93M14.66M5.82M6.61M7.23M5.08M3.97M3.56M2.73M2.56M1.95M2.31M
SG&A % of Revenue57.38%59.65%64.98%80.3%95.8%133.9%438.65%283.3%289.96%110.9%200.97%78.06%227.55%218.93%138.27%273.69%68.95%98.99%99.13%19.23%
Research & Development4.39M2.62M3.43M3.43M3.26M9.91M10.95M10.52M10.71M10.45M12.3M7.43M8.65M-11.31M5.38M22.46M3.08M2.81M2.24M2.85M
R&D % of Revenue12.13%7.68%13.17%13.26%15.97%82.32%296.21%236.48%312.85%79.03%424.77%87.76%272.51%-487.75%187.37%1727.54%77.73%108.79%113.94%23.76%
Other Operating Expenses0316K01000K1000K54K1000K1000K000001000K000000
Operating Income52.15M9.31M4.14M-71.04M-5.36M-15.42M-27.31M-23.8M-20.49M-14.67M-15.36M-6.25M-12.83M-9.25M-6.63M-24.77M-1.86M-2.84M-2.22M5.83M
Operating Margin %143.97%27.3%15.9%-274.48%-26.28%-128.01%-739%-534.84%-598.13%-111%-530.71%-73.81%-404%-399.01%-230.55%-1905.15%-46.89%-110.07%-113.08%48.67%
Operating Income Growth %1072.51%160.42%115.17%-198.55%73.83%-5.08%-77.73%-280.6%-59.66%-58.55%-131.87%74.76%-590.21%-225.58%-198.2%-524.6%-126.71%11.57%-83.18%124.95%
EBITDA52.15M9.68M4.54M-69.39M-3.71M-13.77M-25.69M-22.23M-18.92M-13.88M-15.3M-6.17M-12.75M-8.95M-6.23M-24.59M-1.79M-2.78M-2.16M5.9M
EBITDA Margin %143.97%28.36%17.4%-268.1%-18.2%-114.32%-695.24%-499.73%-552.53%-105.05%-528.57%-72.89%-401.51%-386.07%-216.7%-1891.23%-45.25%-107.59%-109.77%49.2%
EBITDA Growth %1504.42%170.29%117.65%-212.09%80.38%0.84%-67.88%-260.11%-48.4%-55.08%-145.7%74.89%-610.81%-222.28%-188.73%-516.92%-125.54%11.75%-88.22%121.61%
D&A (Non-Cash Add-back)0362K392K1.65M1.65M1.65M1.62M1.56M1.56M787K62K78K79K300K398K181K65K64K65K64K
EBIT014.61M1.07M78.92M52K-18.17M-30.91M-17.75M-15.96M-14.67M-13.5M-2.45M-13.14M-9.04M-6.53M-24.72M-1.86M-2.66M-1.75M6.23M
Net Interest Income1.71M-236K-2.05M-2.01M-1.43M-2.27M-1.26M-1.84M194K-548K1.37M1.36M860K-170K94K330K102K107K131K-25K
Interest Income01.71M00543K-73K1.05M270K929K208K1.74M1.55M1.04M0218K366K107K112K137K0
Interest Expense-1.71M1.95M2.05M2.01M1.97M2.19M2.31M2.11M735K756K366K197K182K170K124K36K5K5K6K25K
Other Income/Expense-7.34M3.35M-5.12M147.94M3.44M-4.95M-5.92M3.94M3.79M-482K5.17M3.6M-489K198K-23K10K-9K173K463K370K
Pretax Income44.8M12.67M-977K76.91M-1.92M-20.37M-33.23M-19.86M-16.69M-15.15M-10.19M-2.65M-13.32M-9.05M-6.65M-24.76M-1.87M-2.67M-1.76M6.2M
Pretax Margin %123.7%37.12%-3.75%297.15%-9.4%-169.13%-899.19%-446.28%-487.36%-114.65%-351.99%-31.25%-419.4%-390.47%-231.35%-1904.38%-47.11%-103.37%-89.52%51.75%
Income Tax-6.91M501K-433K2.2M1.18M15.37M070K-70K0177K-74K-103K-34K-33K-715K-4K34K00
Effective Tax Rate %-15.43%3.96%44.32%2.86%-61.66%-75.47%0%-0.35%0.42%0%-1.74%2.8%0.77%0.38%0.5%2.89%0.21%-1.27%0%0%
Net Income37.89M12.16M-544K74.71M-3.1M-35.74M-33.23M-19.93M-16.62M-15.15M-10.37M-2.57M-13.22M-9.02M-6.62M-24.04M-1.86M-2.7M-1.76M6.2M
Net Margin %104.61%35.65%-2.09%288.66%-15.19%-296.76%-899.19%-447.85%-485.31%-114.65%-358.1%-30.38%-416.15%-389%-230.2%-1849.38%-47.01%-104.69%-89.52%51.75%
Net Income Growth %1322.65%134.04%98.36%474.94%81.36%-135.85%-220.49%-674.39%-25.76%-67.97%-56.7%89.3%-609.07%-233.74%-276.12%-487.59%81.9%44.34%41.54%622.12%
Net Income (Continuing)37.89M12.16M-544K74.71M-3.1M-35.74M-33.23M-19.93M-16.62M-15.15M-10.37M-2.57M-13.22M-9.02M-6.62M-24.04M-1.86M-2.7M-1.76M6.2M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.600.20-0.011.36-0.06-0.67-0.69-0.48-0.40-0.40-0.30-0.15-0.34-0.26-0.19-0.70-0.05-0.08-0.050.21
EPS Growth %1147.12%129.85%98.59%383.33%85.67%-67.5%-130%-220%-17.65%-53.85%-57.89%78.57%-529.63%-239.87%-280.76%-433.33%90%92.85%92.66%0%
EPS (Basic)0.620.21-0.011.36-0.06-0.67-0.69-0.48-0.40-0.40-0.30-0.15-0.34-0.26-0.19-0.70-0.05-0.08-0.050.21
Diluted Shares Outstanding60.23M57.26M55.95M56.32M54.1M53.67M47.81M41.9M41.78M37.9M34.72M33.9M34.47M34.51M34.49M34.45M34.51M35.35M35.22M29.17M
Basic Shares Outstanding58.41M55.31M55.95M54.78M54.1M53.67M47.81M41.9M41.78M37.9M34.72M33.9M34.47M34.51M34.49M34.45M34.51M35.35M35.22M29.17M
Dividend Payout Ratio--------------------